Compare BioNano Genomics Inc (BNGO) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Sunrun Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Sunrun Inc trades at $9.84 (market cap $2.42B). The key difference: Sunrun Inc is far larger — about 177.2× BioNano Genomics Inc's market cap. Which is the better fit depends on your goals.
| BNGO | RUN | |
|---|---|---|
Market Cap | $13.66M | $2.42B |
Sector | Health | Technology |
52-Week High | $4.92 | $21.41 |
52-Week Low | $1.06 | $9.38 |
Enterprise Value | $16.26M | $16.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
Sunrun (RUN) trades at $9.79, down 0.81% amid bearish technical signals despite strong earnings beats. The company shows solid profitability with 11.59% net margin and attractive valuation metrics including P/E of 6.82 and P/B of 0.69. Recent Q2 2026 results beat expectations with $0.42 EPS versus $0.23 estimate, though shares declined on reduced full-year guidance and Goldman Sachs price target cut from $18 to $15.
While fundamentals remain strong with growing storage adoption and positive cash generation, near-term headwinds include guidance reductions and solar sector volatility. Analyst consensus remains bullish with $14.38 price target representing 47% upside potential, but investors face execution risks amid the company's shift toward direct sales and competitive market pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
